QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
NASDAQ:IRMD

IRadimed (IRMD) Stock Forecast, Price & News

$47.07
-0.38 (-0.80%)
(As of 06/6/2023 ET)
Compare
Today's Range
$46.46
$47.29
50-Day Range
$38.88
$48.75
52-Week Range
$26.00
$49.30
Volume
39,471 shs
Average Volume
38,490 shs
Market Capitalization
$593.08 million
P/E Ratio
43.18
Dividend Yield
N/A
Price Target
$49.00

IRadimed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
4.1% Upside
$49.00 Price Target
Short Interest
Healthy
1.20% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
-0.66mentions of IRadimed in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$4.38 M Sold Last Quarter
Proj. Earnings Growth
21.37%
From $1.17 to $1.42 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Medical Sector

252nd out of 981 stocks

Surgical & Medical Instruments Industry

21st out of 97 stocks


IRMD stock logo

About IRadimed (NASDAQ:IRMD) Stock

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Stock News Headlines

“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
IRadimed Co. (NASDAQ:IRMD) CEO Sells $119,091.16 in Stock
IRadimed Co. (NASDAQ:IRMD) CEO Sells $462,000.00 in Stock
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
iRadimed Stock (NASDAQ:IRMD), Dividends
IRadimed (NASDAQ:IRMD) Now Covered by Lake Street Capital
StockNews.com Upgrades IRadimed (NASDAQ:IRMD) to "Strong-Buy"
See More Headlines

IRMD Price History

IRMD Company Calendar

Last Earnings
5/04/2023
Today
6/06/2023
Next Earnings (Estimated)
8/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRMD
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$49.00
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$48.00
Forecasted Upside/Downside
+4.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$12.83 million
Pretax Margin
30.94%

Debt

Sales & Book Value

Annual Sales
$53.30 million
Cash Flow
$1.04 per share
Book Value
$5.86 per share

Miscellaneous

Free Float
7,230,000
Market Cap
$593.21 million
Optionable
Not Optionable
Beta
1.06

Key Executives

  • Roger Susi
    Chairman, President & Chief Executive Officer
  • John F. Glenn
    Chief Financial Officer & Secretary
  • Chris Williamson
    Vice President-Information Technology
  • Lynn Neuhardt
    Vice President-Research & Development
  • Randy Waddell
    VP-Worldwide Sales & Marketing













IRMD Stock - Frequently Asked Questions

Should I buy or sell IRadimed stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IRadimed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRMD shares.
View IRMD analyst ratings
or view top-rated stocks.

What is IRadimed's stock price forecast for 2023?

1 brokerages have issued twelve-month price objectives for IRadimed's stock. Their IRMD share price forecasts range from $48.00 to $50.00. On average, they predict the company's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 4.1% from the stock's current price.
View analysts price targets for IRMD
or view top-rated stocks among Wall Street analysts.

How have IRMD shares performed in 2023?

IRadimed's stock was trading at $28.29 at the start of the year. Since then, IRMD stock has increased by 66.4% and is now trading at $47.08.
View the best growth stocks for 2023 here
.

When is IRadimed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023.
View our IRMD earnings forecast
.

How were IRadimed's earnings last quarter?

IRadimed Co. (NASDAQ:IRMD) posted its quarterly earnings data on Thursday, May, 4th. The medical equipment provider reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.02. The medical equipment provider had revenue of $15.48 million for the quarter, compared to analyst estimates of $14.76 million. IRadimed had a trailing twelve-month return on equity of 20.03% and a net margin of 24.27%.

How often does IRadimed pay dividends? What is the dividend yield for IRadimed?

IRadimed announced a dividend on Monday, February 6th. Stockholders of record on Monday, February 13th will be paid a dividend of $1.05 per share on Tuesday, February 21st. This represents a dividend yield of 2.54%. The ex-dividend date is Friday, February 10th. This is a positive change from the stock's previous dividend of $1.00.
Read our dividend analysis for IRMD
.

What ETFs hold IRadimed's stock?

ETFs with the largest weight of IRadimed (NASDAQ:IRMD) stock in their portfolio include Ballast Small/Mid Cap ETF (MGMT), Janus Henderson Small Cap Growth Alpha ETF (JSML), Royce Quant Small-Cap Quality Value ETF (SQLV),

What guidance has IRadimed issued on next quarter's earnings?

IRadimed updated its second quarter 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of $0.30-$0.32 for the period, compared to the consensus EPS estimate of $0.30. The company issued revenue guidance of $15.60 million-$15.80 million, compared to the consensus revenue estimate of $15.10 million.

What other stocks do shareholders of IRadimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

What is IRadimed's stock symbol?

IRadimed trades on the NASDAQ under the ticker symbol "IRMD."

Who are IRadimed's major shareholders?

IRadimed's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (4.61%), BlackRock Inc. (3.52%), RK Capital Management LLC (2.66%), Bares Capital Management Inc. (2.52%), Russell Investments Group Ltd. (1.69%) and Ranger Investment Management L.P. (1.63%). Insiders that own company stock include Anthony Vuoto, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi.
View institutional ownership trends
.

How do I buy shares of IRadimed?

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IRadimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $47.08.

How much money does IRadimed make?

IRadimed (NASDAQ:IRMD) has a market capitalization of $593.21 million and generates $53.30 million in revenue each year. The medical equipment provider earns $12.83 million in net income (profit) each year or $1.09 on an earnings per share basis.

How many employees does IRadimed have?

The company employs 110 workers across the globe.

How can I contact IRadimed?

IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037.

This page (NASDAQ:IRMD) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -